Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CALMARK-MBZ is an oral multi-mineral supplement developed by Medimark Biotech, specifically formulated for the company's gynecology product range. It contains a combination of calcium citrate, magnesium hydroxide, zinc sulfate, and boron. This formulation is designed to support bone health and mineral density, making it particularly relevant for women during pregnancy, lactation, and the post-menopausal period to prevent or treat conditions like osteoporosis and calcium deficiency. Calcium citrate provides a highly bioavailable source of calcium for bone mineralization, while magnesium, zinc, and boron serve as essential cofactors and structural components that enhance calcium absorption and bone tissue metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium citrate + magnesium hydroxide + zinc sulfate + boron.